Activation of the NF-kappaB pathway by caspase 8 and its homologs
about
Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory proteinS-nitrosylation of FLICE inhibitory protein determines its interaction with RIP1 and activation of NF-kappa BFas-associated factor-1 inhibits nuclear factor-kappaB (NF-kappaB) activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-kappaBCaspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiationA novel function of caspase-8 in the regulation of androgen-receptor-driven gene expressionControl of autophagic cell death by caspase-10 in multiple myelomaFLICE-inhibitory proteins: regulators of death receptor-mediated apoptosisThe Fas-associated death domain protein suppresses activation of NF-kappa B by LPS and IL-1 betaNew insights into the role of nuclear factor-kB in cell growth regulationModulation of the host innate immune and inflammatory response by translocated bacterial proteinsCellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complexInduction of marked apoptosis in mammalian cancer cell lines by antisense DNA treatment to abolish expression of DENN (differentially expressed in normal and neoplastic cells)Death effector domain-containing proteins DEDD and FLAME-3 form nuclear complexes with the TFIIIC102 subunit of human transcription factor IIICFas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammationFADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosisc-FLIP, a master anti-apoptotic regulatorTIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasisFas Ag-FasL coupling leads to ERK1/2-mediated proliferation of gastric mucosal cellsN-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathwayUbiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signalingCaspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.HIV infection enhances TRAIL-induced cell death in macrophage by down-regulating decoy receptor expression and generation of reactive oxygen species.TCR-induced, PKC-θ-mediated NF-κB activation is regulated by a caspase-8-caspase-9-caspase-3 cascade.Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growth.Roles of c-FLIP in Apoptosis, Necroptosis, and Autophagy.The role of cellular FLICE inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer.The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation.The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection.HBx-induced NF-κB signaling in liver cells is potentially mediated by the ternary complex of HBx with p22-FLIP and NEMO.Fas-associated death domain (FADD) and the E3 ubiquitin-protein ligase TRIM21 interact to negatively regulate virus-induced interferon productionDNA methylation in thyroid tumorigenesis.FLICE-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kappaB activation induced by bacterial lipopolysaccharideThe role of CD95 in the regulation of peripheral T-cell apoptosis.Anticancer Effect of Ursodeoxycholic Acid in Human Oral Squamous Carcinoma HSC-3 Cells through the Caspases.Genome-wide association analysis identified splicing single nucleotide polymorphism in CFLAR predictive of triptolide chemo-sensitivity.Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.Caspases leave the beaten track: caspase-mediated activation of NF-kappaB.Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.Cystic fibrosis transmembrane conductance regulator controls lung proteasomal degradation and nuclear factor-kappaB activity in conditions of oxidative stress.
P2860
Q23919035-9C774A22-A833-4C3A-98CC-59F6643919CCQ23921468-9F517B21-0C9E-4C74-A73D-CEE65FD2ED84Q24299181-134E7C84-81F8-437E-BAC4-DADBA1E0782EQ24307493-60BA20F0-33A7-40C3-A7F5-4B7121C505E9Q24336995-EE917D41-E646-44F1-8FDD-E72120822A35Q24337539-B813BD3B-29C3-4F39-94B5-EFC9321D13F4Q24548247-5693A630-25F0-402E-95E0-42DA9B0FCE6DQ24551184-D5D649ED-DDA1-4D58-A96C-7263E133A86CQ26058119-8A233028-9CA0-4416-AA13-4C45C2E9B017Q28083042-1BA7E8A6-F983-4671-9ACA-29B7B992D7B8Q28209029-310BE19E-FA0C-4282-A4C5-AAE97FCC84ACQ28212632-B4D54BD6-79FC-4AC6-A8C2-E3561792C472Q28215325-FEA135C8-A95F-43FF-BD5C-49C8DBB16737Q28248826-96FBAA0C-2CF9-423A-B086-A8EF0F658411Q28389564-ADC98602-8CCA-4B6D-8217-394253053562Q28391119-4A132A9A-3C92-4192-ACB2-06DE9DDDB86FQ28509230-D2C86904-D725-42D8-B89F-7EB87C0FB222Q28566013-F67D960A-F974-4C54-92A5-7E0957AB1D53Q28629323-592BC17E-06CC-4261-B549-70E6B4C56136Q28757756-930623D3-179E-4B0C-ADEF-DF7EDB5D61EFQ33529488-2E178B61-F965-477D-9ACC-03CA3411EB2FQ33869186-5775AAB2-5905-4F50-B007-B76D6B3AF669Q33934492-B89432EC-C399-4FAB-85E2-A3156F2B638BQ34345398-61B757EF-C27C-4073-BE6A-8AA4DD0FE25DQ34449938-F642DB10-3FE0-4E73-8065-2151E35F869EQ34488806-9EDF84B9-9450-4F16-8ED5-D98DA61DF06EQ34542601-FDF1662B-B5DB-412A-8C0A-6D1A08147D9DQ34596147-1429A8F6-59FF-492F-942E-4A1B7D0BC3EAQ34618294-A7D05725-D3D3-4221-A651-CE618D258F4DQ34675854-3449C410-61FA-4BA6-84B1-8DCEA24112F3Q35086482-8DEA3783-6E9F-40B5-8A91-B3905CBA8B97Q35103246-D86589C2-E21E-468B-8F4B-B2ECCD934CCAQ35129712-66B3CD83-314A-4307-BBB0-644276292688Q35658032-CA9B0044-9AB3-4E16-BE0D-302CCC436587Q35677567-7C10F3D7-9C03-4B33-8FFF-8C80BE756321Q35762274-76FBE211-7A11-4002-86A1-6EE24A56CE5AQ35915103-BEFE5033-8A02-4FF7-9C6F-AEC921264453Q36450945-51663B66-7AFC-4B77-B71D-6314CC2F0385Q36500552-4686BC3B-5A7F-43DC-AA61-184E0D220D03Q36579774-8BD8EF07-4060-48A5-9877-4CFE92732489
P2860
Activation of the NF-kappaB pathway by caspase 8 and its homologs
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Activation of the NF-kappaB pathway by caspase 8 and its homologs
@ast
Activation of the NF-kappaB pathway by caspase 8 and its homologs
@en
Activation of the NF-kappaB pathway by caspase 8 and its homologs
@nl
type
label
Activation of the NF-kappaB pathway by caspase 8 and its homologs
@ast
Activation of the NF-kappaB pathway by caspase 8 and its homologs
@en
Activation of the NF-kappaB pathway by caspase 8 and its homologs
@nl
prefLabel
Activation of the NF-kappaB pathway by caspase 8 and its homologs
@ast
Activation of the NF-kappaB pathway by caspase 8 and its homologs
@en
Activation of the NF-kappaB pathway by caspase 8 and its homologs
@nl
P2093
P3181
P356
P1433
P1476
Activation of the NF-kappaB pathway by caspase 8 and its homologs
@en
P2093
P2888
P304
P3181
P356
10.1038/SJ.ONC.1203812
P407
P577
2000-09-14T00:00:00Z
P5875
P6179
1011612762